Tedros Adhano Ghebreyasus, director general of WHO (World Health Organization) has recently announced the broad use of the world’s first malaria vaccine.
Malaria is mosquito-prone disease that kill more 4 lakh people every year, majorly in African countries. It is a parasite disease with five species causing symptoms of headache, fever, muscle pain, chills and sweating.
Now WHO on October 6, 2021 recommended the RTS, S/AS01 malaria vaccine which is world’ first vaccine for deadly disease. The world’ first anti-malarial named Mosquirix is manufactured by British drugmaker company GlaxoSmithKline (GSK).
According to WHO, first preference of the use of the vaccine should be for children. The primary focus will be widespread use of vaccine among children in Sub-Saharan Africa and other vulnerable countries with moderate to high malaria transmission. Four doses will be given up to the age of two years.
Tedros said this is a historic moment as vaccine is a breakthrough for science and RTS, S malaria vaccine is a gift to the world that took more than 30 years to develop such vaccine against malaria. Mosquirix will be the first vaccine against human parasite recommended by WHO.